1. Home
  2. LGND vs DBRG Comparison

LGND vs DBRG Comparison

Compare LGND & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • DBRG
  • Stock Information
  • Founded
  • LGND 1987
  • DBRG 1991
  • Country
  • LGND United States
  • DBRG United States
  • Employees
  • LGND N/A
  • DBRG N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • DBRG Real Estate Investment Trusts
  • Sector
  • LGND Health Care
  • DBRG Real Estate
  • Exchange
  • LGND Nasdaq
  • DBRG Nasdaq
  • Market Cap
  • LGND 2.0B
  • DBRG 1.8B
  • IPO Year
  • LGND 1992
  • DBRG 2009
  • Fundamental
  • Price
  • LGND $122.40
  • DBRG $10.40
  • Analyst Decision
  • LGND Strong Buy
  • DBRG Strong Buy
  • Analyst Count
  • LGND 8
  • DBRG 9
  • Target Price
  • LGND $144.71
  • DBRG $16.17
  • AVG Volume (30 Days)
  • LGND 139.7K
  • DBRG 2.8M
  • Earning Date
  • LGND 08-05-2025
  • DBRG 08-06-2025
  • Dividend Yield
  • LGND N/A
  • DBRG 0.39%
  • EPS Growth
  • LGND N/A
  • DBRG N/A
  • EPS
  • LGND N/A
  • DBRG 0.32
  • Revenue
  • LGND $181,488,000.00
  • DBRG $566,324,000.00
  • Revenue This Year
  • LGND $18.41
  • DBRG N/A
  • Revenue Next Year
  • LGND $18.87
  • DBRG $24.41
  • P/E Ratio
  • LGND N/A
  • DBRG $32.21
  • Revenue Growth
  • LGND 53.40
  • DBRG N/A
  • 52 Week Low
  • LGND $81.74
  • DBRG $6.41
  • 52 Week High
  • LGND $129.90
  • DBRG $17.33
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • DBRG 51.34
  • Support Level
  • LGND $111.72
  • DBRG $10.21
  • Resistance Level
  • LGND $115.53
  • DBRG $10.79
  • Average True Range (ATR)
  • LGND 3.46
  • DBRG 0.36
  • MACD
  • LGND 0.18
  • DBRG -0.01
  • Stochastic Oscillator
  • LGND 85.52
  • DBRG 66.91

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

Share on Social Networks: